Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Milk study scans bellies to see how Low-Lactose plus GOS affects digestion

NCT ID NCT06598124

Knowledge-focused Sponsor: Société des Produits Nestlé (SPN) Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study looked at how a single serving of low lactose milk with added GOS (a type of fiber) affects digestion compared to regular milk. Twenty-four healthy Chinese adults drank 400 mL of one milk type, and researchers used MRI scans to measure stomach emptying, small bowel water, and gut movement. The goal was simply to understand digestive responses, not to treat any disease.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
low lactose milk with galactooligosaccharides (GOS)

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

24 people

The number who actually took part.

Started

Aug 2024

Finished

Jun 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Participants declare that they are of Chinese ethnicity as well as both of their biological parents 2. Women and men aged between 18 and 60 years 3. Body mass index (BMI ≥ 18.5 \& \<30 kg/m2) 4. Healthy: no medical conditions or previous gastrointestinal surgery which might affect study measurements (as declared by the participant) 5. Able to understand and to sign written informed consent prior to study entry 6. Informed consent signed 7. Meets all the criteria for MRI Scan 8. Can read and speak English Exclusion Criteria: 1. Medically diagnosed milk allergy 2. Subjects not willing and/or not able to comply with scheduled visits and the requirements of the study protocol 3. Diagnosed with any gastrointestinal disorders 4. History of claustrophobia 5. Pregnant (defined by pregnancy test) or breast feeding 6. History or current psychiatric illness 7. History or current neurological condition (e.g. epilepsy) 8. Consumption of \> 21 alcoholic drinks in a typical week (one serving is 0.4 dl of spirits, 1 dl of wine, or 3 dl of beer as declared by participant) 9. Currently smoking (as declared by participant) 10. Having taken part in a research study in the last 3 months involving invasive procedures or an inconvenience allowance 11. Antibiotic use within the 4 weeks preceding the intervention 12. Probiotic \& prebiotics use within the 2 weeks preceding the intervention

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Healthy

Contacts and locations

Locations

  • University of Nottingham

    Nottingham, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.